Showing results (161-170 of 169) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
The Lancet. Oncology|November 23, 2015
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialAndreas du Bois, Gunnar Kristensen, Isabelle Ray-Coquard, et al.Acta Neuropathologica Communications|October 23, 2022
Plasma proteome profiling identifies changes associated to AD but not to FTDR Babapour Mofrad, M Del Campo, C F W Peeters, et al.Medicina Intensiva|March 1, 2022
ADENI-UCI study: Analysis of non-income decisions in ICU as a measure of limitation of life support treatmentsP Escudero-Acha, O Leizaola, N Lázaro, et al.Medicina Intensiva|January 2, 2021
ADENI-UCI Study: Analysis of non-income decisions in ICU as a measure of limitation of life support treatmentsP Escudero-Acha, O Leizaola, N Lázaro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian CancerRachel N Grisham, Ignace Vergote, Susana Banerjee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary PeritoneumBradley J Monk, Rachel N Grisham, Susana Banerjee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2014
Incorporation of pazopanib in maintenance therapy of ovarian cancerAndreas du Bois, Anne Floquet, Jae-Weon Kim, et al.The Journal of Clinical Endocrinology and Metabolism|February 13, 2010
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex developmentL Audi, M Fernández-Cancio, A Carrascosa, et al.Clinical Genetics|January 17, 2013
MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype studyP Makrythanasis, B W van Bon, M Steehouwer, et al.Pageof 17